Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (471-480 of 903) with videos related to

Pageof 91
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer diseaseTeresa Montez, Simon-Shlomo Poil, Bethany F Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 10, 2010
Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAASAnn I Scher, Yuan Xu, Esther S C Korf, et al.
Brain : a Journal of Neurology|August 25, 2020
A clinical-radiological framework of the right temporal variant of frontotemporal dementiaHulya Ulugut Erkoyun, Colin Groot, Ronja Heilbron, et al.
Alzheimer'S Research & Therapy|January 9, 2020
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCIJolien F Leijenaar, Geert Jan Groeneveld, Erica S Klaassen, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services-part 1 of 6Daniele Altomare, José Luis Molinuevo, Craig Ritchie, et al.
European Journal of Epidemiology|October 27, 2018
The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort descriptionHenne Holstege, Nina Beker, Tjitske Dijkstra, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's diseaseNienke M E Scheltens, Ingrid S Kuyper, Ronald Boellaard, et al.
Annals of Neurology|February 21, 2013
Diffusion changes predict cognitive and functional outcome: the LADIS studyHanna Jokinen, Reinhold Schmidt, Stefan Ropele, et al.
Alzheimer'S Research & Therapy|October 13, 2018
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a studyPhilip Scheltens, Merja Hallikainen, Timo Grimmer, et al.
Pageof 91

Showing results (471-480 of 903) with videos related to

Sort By:
Pageof 91
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer diseaseTeresa Montez, Simon-Shlomo Poil, Bethany F Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 10, 2010
Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAASAnn I Scher, Yuan Xu, Esther S C Korf, et al.
Brain : a Journal of Neurology|August 25, 2020
A clinical-radiological framework of the right temporal variant of frontotemporal dementiaHulya Ulugut Erkoyun, Colin Groot, Ronja Heilbron, et al.
Alzheimer'S Research & Therapy|January 9, 2020
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCIJolien F Leijenaar, Geert Jan Groeneveld, Erica S Klaassen, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services-part 1 of 6Daniele Altomare, José Luis Molinuevo, Craig Ritchie, et al.
European Journal of Epidemiology|October 27, 2018
The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort descriptionHenne Holstege, Nina Beker, Tjitske Dijkstra, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's diseaseNienke M E Scheltens, Ingrid S Kuyper, Ronald Boellaard, et al.
Annals of Neurology|February 21, 2013
Diffusion changes predict cognitive and functional outcome: the LADIS studyHanna Jokinen, Reinhold Schmidt, Stefan Ropele, et al.
Alzheimer'S Research & Therapy|October 13, 2018
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a studyPhilip Scheltens, Merja Hallikainen, Timo Grimmer, et al.
Pageof 91